These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18644885)

  • 1. Host biomarkers and biological pathways that are associated with the expression of experimental cerebral malaria in mice.
    Oakley MS; McCutchan TF; Anantharaman V; Ward JM; Faucette L; Erexson C; Mahajan B; Zheng H; Majam V; Aravind L; Kumar S
    Infect Immun; 2008 Oct; 76(10):4518-29. PubMed ID: 18644885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral Malaria Is Regulated by Host-Mediated Changes in
    Cimperman CK; Pena M; Gokcek SM; Theall BP; Patel MV; Sharma A; Qi C; Sturdevant D; Miller LH; Collins PL; Pierce SK; Akkaya M
    mBio; 2023 Apr; 14(2):e0339122. PubMed ID: 36852995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular correlates of experimental cerebral malaria detectable in whole blood.
    Oakley MS; Anantharaman V; Venancio TM; Zheng H; Mahajan B; Majam V; McCutchan TF; Myers TG; Aravind L; Kumar S
    Infect Immun; 2011 Mar; 79(3):1244-53. PubMed ID: 21149594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria.
    Lovegrove FE; Peña-Castillo L; Mohammad N; Liles WC; Hughes TR; Kain KC
    BMC Genomics; 2006 Nov; 7():295. PubMed ID: 17118208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice.
    Delahaye NF; Coltel N; Puthier D; Barbier M; Benech P; Joly F; Iraqi FA; Grau GE; Nguyen C; Rihet P
    BMC Genomics; 2007 Dec; 8():452. PubMed ID: 18062806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
    Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
    Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria.
    DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA
    Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.
    Torre S; Langlais D; Gros P
    Mamm Genome; 2018 Aug; 29(7-8):488-506. PubMed ID: 29922917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
    Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.
    Randall LM; Amante FH; McSweeney KA; Zhou Y; Stanley AC; Haque A; Jones MK; Hill GR; Boyle GM; Engwerda CR
    Infect Immun; 2008 Jul; 76(7):3312-20. PubMed ID: 18474652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.
    Oakley MS; Majam V; Mahajan B; Gerald N; Anantharaman V; Ward JM; Faucette LJ; McCutchan TF; Zheng H; Terabe M; Berzofsky JA; Aravind L; Kumar S
    PLoS One; 2009 Aug; 4(8):e6793. PubMed ID: 19710907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
    Keita Alassane S; Nicolau-Travers ML; Menard S; Andreoletti O; Cambus JP; Gaudre N; Wlodarczyk M; Blanchard N; Berry A; Abbes S; Colongo D; Faye B; Augereau JM; Lacroux C; Iriart X; Benoit-Vical F
    PLoS One; 2017; 12(7):e0181300. PubMed ID: 28742109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
    Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
    Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a ¹H NMR spectroscopy-based metabonomic study.
    Ghosh S; Sengupta A; Sharma S; Sonawat HM
    J Proteome Res; 2012 Oct; 11(10):4992-5004. PubMed ID: 22838963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.
    Amani V; Boubou MI; Pied S; Marussig M; Walliker D; Mazier D; Rénia L
    Infect Immun; 1998 Sep; 66(9):4093-9. PubMed ID: 9712753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.
    Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; Rodrigues CD; Gregoire IP; Cunha-Rodrigues M; Portugal S; Soares MP; Mota MM
    Nat Med; 2007 Jun; 13(6):703-10. PubMed ID: 17496899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content.
    Tiberti N; Latham SL; Bush S; Cohen A; Opoka RO; John CC; Juillard A; Grau GE; Combes V
    Sci Rep; 2016 Dec; 6():37871. PubMed ID: 27917875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice.
    Akkaya M; Bansal A; Sheehan PW; Pena M; Cimperman CK; Qi CF; Yazew T; Otto TD; Billker O; Miller LH; Pierce SK
    Sci Rep; 2020 Aug; 10(1):13630. PubMed ID: 32788672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 blockade reduces the pathologic features of experimental cerebral malaria and promotes survival of hosts with
    Torrez Dulgeroff LB; Oakley MS; Tal MC; Yiu YY; He JQ; Shoham M; Majam V; Okoth WA; Malla P; Kumar S; Weissman IL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.